Skip to main content

Alpha Cognition Inc(ACOG-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low6.78
Day High7.06
Open:6.87
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Business Wire
Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig
Business Wire
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tipranks
Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG), Insmed (INSM) and Connect Biopharma Holdings (CNTB)
Tipranks
Alpha Cognition Earnings Call: Early Traction, Rising Costs
Business Wire
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury
Motley Fool
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript
Business Wire
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update
Motley Fool
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year
Motley Fool
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue
Business Wire
Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences
Motley Fool
Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought
Tipranks
Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG) and Fulcrum Therapeutics (FULC)
Business Wire
Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study
Business Wire
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
Business Wire
Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution
Business Wire
Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners
Tipranks
Analysts Offer Insights on Healthcare Companies: Co-Diagnostics (CODX), Stevanato Group (STVN) and Alpha Cognition Inc (ACOG)
Tipranks
Alpha Cognition’s Earnings Call: Strong Sales and Strategic Growth
Business Wire
Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update
Business Wire
Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025
Tipranks
Alpha Cognition Inc. Raises $35 Million in Oversubscribed Public Offering
Tipranks
Alpha Cognition Inc. Announces Public Offering to Boost Alzheimer’s Treatment Launch
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Alpha Cognition Inc (ACOG) and Exelixis (EXEL)
TheNewswire.com
Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
Business Wire
Alpha Cognition to Present Clinical Data at Consultant Pharmacy and Neuroscience Education Institute Meetings
Business Wire
Alpha Cognition to Present Clinical Data at ASCP Annual Meeting
Business Wire
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares
Business Wire
Alpha Cognition Inc. Announces Proposed Public Offering of Common Shares
Business Wire
Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences
Tipranks
Alpha Cognition Inc. Reports Strong Q2 2025 Results
Business Wire
Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update
Business Wire
Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview

Profile

Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.